Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where A. Le Faou is active.

Publication


Featured researches published by A. Le Faou.


Journal of Hospital Infection | 1991

Multiresistant corynebacteria in bacteriuria: A comparative study of the role of Corynebacterium group D2 and Corynebacterium jeikeium

D. De Briel; J.C. Langs; G. Rougeron; P. Chabot; A. Le Faou

During an 11-month prospective study, urine cultures were performed on 5685 samples obtained in three hospital units. The use of a selective medium improved the recovery of antibiotic-multiresistant corynebacteria (AMC): 703 isolates (12.4%) compared with 88 isolates (1.6%) on sheep blood agar. Corynebacterium group D2 (CGD2) was isolated in 80.5% of urines yielding greater than or equal to 10(5) AMC ml-1 whereas Corynebacterium jeikeium represented 80.2% of isolates with less than 10(5) AMC ml-1. Among 16 patients with greater than or equal to 10(5) ml-1 C. jeikeium none had signs of urinary tract infection. In contrast, among 56 patients with greater than or equal to 10(5) CGD2, 40 (71%) had abnormal urinary sediment (mainly apatite or struvite crystals) and 29 (52%) had clinical signs of urinary tract infections sometimes complicated by lithiasis (seven cases) and alkaline-encrusted cystitis (two cases).


Journal of Medical Virology | 2000

Hepatitis B virus X gene variability in French-born patients with chronic hepatitis and hepatocellular carcinoma

Véronique Venard; Daniele Corsaro; C. Kajzer; Jean-Pierre Bronowicki; A. Le Faou

The polymorphism of the hepatitis B virus (HBV) X gene from patients born in Lorraine has been studied in serum samples from 22 HBV infected patients, 14 presenting with chronic hepatitis and 8 with hepatocellular carcinoma (HCC). Subtypes adw and ayw represented 21 of the 22 sequenced isolates. The sequence of the X gene of HBV strains from these patients differed from the ones of Far East origin by A to T1678 and G to A1759 changes for subtype ayw and C to T1792 for adw.


Archives of Virology | 2000

A convenient semi-quantitative method for the diagnosis of Epstein-Barr virus reactivation

Véronique Venard; A.-S. Carret; N. Pascal; B. Rihn; P. Bordigoni; A. Le Faou

Summary.  A semi-quantitative determination of Epstein-Barr virus (EBV) viremia has been devised. Peripheral blood mononuclear cells are recovered by Ficoll gradient and numerated. Five μl aliquots of recovered cell suspension and 5 μl of two standard dilutions (containing 500 and 100 cells, respectively) are subjected to a nested polymerase chain reaction (PCR). This technique has been evaluated over 3 years for the follow-up of 45 patients attending the Bone Marrow Transplantation Unit of the “Centre Hospitalier et Universitaire de Nancy”. EBV reactivation was diagnosed in 13 patients (28%). Positivity of PCR for 100 cells was found in 9 patients of whom 6 developed lymphoma or lymphoproliferative disorder. This technique is easy to perform and doesn’t necessitate any specific material besides the one necessary for routine genic amplification.


Pathologie Biologie | 2001

Infection due to aciclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoetic stem cell transplantation

Véronique Venard; J.-N. Dauendorffer; A.-S. Carret; Daniele Corsaro; D. Edert; P Bordigoni; A. Le Faou

Abstract Over an eight-month period from October 1997 to May 1998, four patients who had received bone marrow transplant (BMT) from unrelated donor presented with severe mucosal cutaneous infections involving aciclovir resistant herpes simplex virus 1 (HSV-1). The four isolates were aciclovir (ACV) resistant, three of which were also foscarnet resistant as determined by the dye uptake method. The sequencing of the thymidine kinase (TK) gene did not permit to establish a relation between mutations and resistance to ACV. Three patients were considered as clinically cured of their HSV infection by replacement of ACV or foscarnet with either valaciclovir (one case) or cidofovir (two cases) but eventually two of them died of graft vs host disease. One patient died of extensive HSV infection despite administration of cidofovir. This study emphasizes the importance of monitoring the herpes virus resistance to antiviral drugs in bone marrow transplant recipients and the usefulness of the evaluation of novel antiviral drug for treatment of infections due to strains of HSV resistant to ACV and foscarnet that occur in about 5% of immunocompromised patients.


Journal of Virological Methods | 2000

A simple method for the in vitro study of the virucidal activity of disinfectants

S Valot; D. Edert; A. Le Faou

For the study of the virucidal activity of a disinfectant by the gel filtration or the dilution methods, the concentration of virus has to be high enough to determine a decrease in titer of at least 4 logarithm units. A filtration technique for rapid separation of the disinfectant and the virus is described that overcome this limitation. The method is applicable to any chemical compound and gives results equivalent to those of the techniques required by the French norms (NF T 72-180).


Chemotherapy | 2000

Susceptibility of Clinical Strains of Herpes simplex Virus to Three Nucleoside Analogues

D. Edert; Chantal Finance; A. Le Faou

The susceptibility of clinical isolates of herpes simplex virus 1 (HSV1) (58 strains) and 2 (HSV2) (17 strains) from the Centre Hospitalier et Universitaire de Nancy to three nucleoside analogues was compared by the dye uptake method. As expected, all strains of HSV2 were resistant to brovavir or sorivudine. Aciclovir and penciclovir activities were comparable; 2 strains of HSV1 were resistant to these two compounds. Four strains isolated from immunocompromised patients gave different results with brovavir as compared to aciclovir; resistance to aciclovir (1 strain of HSV1) did not correlate with resistance to brovavir (3 strains of HSV1). Following up antiviral susceptibility is of interest for the detection of resistant strains in immunocompromised patients receiving prophylactic aciclovir.


Journal of Clinical Pathology | 1999

Molecular epidemiology of ocular isolates of adenovirus 8 obtained over nine years.

Daniele Corsaro; J. P. Gut; Véronique Venard; A. Le Faou

Twenty nine strains of adenovirus 8 have been isolated over nine years in Strasbourg, France, 22 of which were from one private ophthalmologist. To assess a possible relation between these strains, the DNA of adenovirus was analysed by restriction fragment length polymorphism using eight different enzymes. Among these, three proved discriminant (Xba I, Bgl II, Eco RI) and made it possible to define 13 genotypes differing from each other by one to three DNA bands. Seven genotypes were unique isolates, while three, representing 16 strains, were isolated over five to eight years. All the genotypes but one were closely related, with 87% homology. All 13 differed from an adenovirus 8 strain from Lyon (homology 68-76%). This study confirmed the stability of adenovirus 8 in a given population.


Journal of Hospital Infection | 2000

Genotyping of adenoviruses isolated in an outbreak in a bone marrow transplant unit shows that diverse strains are involved

Véronique Venard; A.-S. Carret; Daniele Corsaro; P. Bordigoni; A. Le Faou


Oral Microbiology and Immunology | 2002

Isolation of the provisionally named Desulfovibrio fairfieldensis from human periodontal pockets

Julien Loubinoux; C. Bisson-Boutelliez; N. Miller; A. Le Faou


Tissue & Cell | 2000

Stimulation of rat cutaneous fibroblasts and their synthetic activity by implants of powdered nacre (mother of pearl).

E. Lopez; A. Le Faou; S. Borzeix; S. Berland

Collaboration


Dive into the A. Le Faou's collaboration.

Top Co-Authors

Avatar

Véronique Venard

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

D. Edert

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Daniele Corsaro

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

A.-S. Carret

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

P. Bordigoni

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Chantal Finance

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Francine Kedzierewicz

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

J.-N. Dauendorffer

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

A. Marsura

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

B. Rihn

Centre national de la recherche scientifique

View shared research outputs
Researchain Logo
Decentralizing Knowledge